Skip to content

APOPHAR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOPHAR

BE 0768.405.096
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€3,133
2024 · €205,570-€202,437
Equity
€697,083
2024 · €693,950+€3,133
Cash
€240,000
2024 · €138,783+€101,217
Balance sheet total
€5.3m
2024 · €4.3m+€1.1m

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets +€1.1m

    up €1.1m (+332.4%), from €324,658 to €1.4m

  • Cash +€101,217

    up €101,217 (+72.9%), from €138,783 to €240,000

    mainly Other debts (+€446,797) and Debts after one year (+€392,989)

Equity and liabilities
  • Other debts +€446,797

    up €446,797 (+50.9%), from €877,981 to €1.3m

  • Debts after one year +€392,989

    up €392,989 (+21.7%), from €1.8m to €2.2m

  • Trade debts +€91,000

    up €91,000 (+14.7%), from €617,636 to €708,636

  • Current portion of long-term debt +€57,074

    up €57,074 (+34.2%), from €166,772 to €223,846

Income statement
  • Staff costs +€113,283

    up €113,283 (+30.2%), from €375,103 to €488,385

  • Depreciation +€68,500

    up €68,500 (+64.9%), from €105,482 to €173,982

  • Financial charges +€58,585

    up €58,585 (+85.9%), from €68,182 to €126,767

  • Taxes -€44,946

    down €44,946 (-75.3%), from €59,715 to €14,769

  • Gross operating margin -€15,106

    down €15,106 (-1.9%), from €808,217 to €793,112

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €205,570
Gross operating margin -€15,106
Staff costs -€113,283
Depreciation -€68,500
Other operating charges +€2,089
Financial income +€6,001
Financial charges -€58,585
Taxes +€44,946
Result 2025 €3,133

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€823,945
Investment -€1.2m
Financing +€450,063
Cash 2024 €138,783
Net result for the year +€3,133
Depreciation +€173,982
Stocks and contracts +€23,548
Receivables within one year +€30,357
Deferred charges and accrued income -€4,237
Trade debts +€91,000
Tax, wage and social debts +€27,487
Other debts +€446,797
Accrued charges and deferred income +€31,879
Investment in fixed assets (net) -€1.2m
Current investments +€33,900
Debts after one year +€392,989
Current portion of long-term debt +€57,074
Cash 2025 €240,000
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €4,282,812 €5,333,170 +€1.1m +24.5%
Fixed assets 21/28 €3,338,127 €4,370,836 +€1.0m +30.9%
Intangible fixed assets 21 €324,658 €1,403,973 +€1.1m +332.4%
Tangible fixed assets 22/27 €416,396 €369,791 -€46,606 -11.2%
Plant, machinery and equipment 23 €3,194 €7,609 +€4,415 +138.2%
Furniture and vehicles 24 €13,746 €10,834 -€2,912 -21.2%
Other tangible fixed assets 26 €399,456 €351,347 -€48,109 -12.0%
Assets under construction and advance payments 27 €0 - =
Financial fixed assets 28 €2,597,073 €2,597,073 = 0.0%
Current assets 29/58 €944,686 €962,334 +€17,648 +1.9%
Stocks and contracts in progress 3 €274,208 €250,660 -€23,548 -8.6%
Stocks 30/36 €274,208 €250,660 -€23,548 -8.6%
Amounts receivable within one year 40/41 €400,778 €370,421 -€30,357 -7.6%
Trade receivables 40 €158,930 €216,348 +€57,418 +36.1%
Other amounts receivable 41 €241,848 €154,073 -€87,775 -36.3%
Current investments 50/53 €130,916 €97,016 -€33,900 -25.9%
Cash at bank and in hand 54/58 €138,783 €240,000 +€101,217 +72.9%
Deferred charges and accrued income 490/1 €0 €4,237 +€4,237
Total equity and liabilities 10/49 €4,282,812 €5,333,170 +€1.1m +24.5%
Equity 10/15 €693,950 €697,083 +€3,133 +0.5%
Contributions 10/11 €150,000 €150,000 = 0.0%
Profit (loss) carried forward 14 €543,950 €547,083 +€3,133 +0.6%
Amounts payable 17/49 €3,588,862 €4,636,087 +€1.0m +29.2%
Amounts payable after more than one year 17 €1,810,313 €2,203,302 +€392,989 +21.7%
Financial debts 170/4 €1,810,313 €2,203,302 +€392,989 +21.7%
Amounts payable within one year 42/48 €1,778,465 €2,400,823 +€622,357 +35.0%
Current portion of amounts payable after more than one year 42 €166,772 €223,846 +€57,074 +34.2%
Trade debts 44 €617,636 €708,636 +€91,000 +14.7%
Suppliers 440/4 €617,636 €708,636 +€91,000 +14.7%
Taxes, remuneration and social security 45 €116,075 €143,562 +€27,487 +23.7%
Taxes 450/3 €37,549 €45,923 +€8,374 +22.3%
Remuneration and social security 454/9 €78,527 €97,639 +€19,112 +24.3%
Other amounts payable 47/48 €877,981 €1,324,778 +€446,797 +50.9%
Accrued charges and deferred income 492/3 €83 €31,962 +€31,879 +38200.8%
Remuneration, social security and pensions 62 €375,103 €488,385 +€113,283 +30.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €105,482 €173,982 +€68,500 +64.9%
Other operating charges 640/8 €3,088 €998 -€2,089 -67.7%
Gross operating margin 9900 €808,217 €793,112 -€15,106 -1.9%
Operating profit (loss) 9901 €324,545 €129,746 -€194,798 -60.0%
Financial income 75/76B €8,922 €14,923 +€6,001 +67.3%
Recurring financial income 75 €8,922 €14,923 +€6,001 +67.3%
Financial charges 65/66B €68,182 €126,767 +€58,585 +85.9%
Recurring financial charges 65 €68,182 €126,767 +€58,585 +85.9%
Profit (loss) for the period before taxes 9903 €265,285 €17,902 -€247,383 -93.3%
Income taxes 67/77 €59,715 €14,769 -€44,946 -75.3%
Profit (loss) for the period 9904 €205,570 €3,133 -€202,437 -98.5%
Profit (loss) for the period to be appropriated 9905 €205,570 €3,133 -€202,437 -98.5%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.